A single center, randomized, controlled study to determine the irritant potential of topical acne formulations on intact healthy skin on the back following repeated application during a 21-day treatment period

Trial Profile

A single center, randomized, controlled study to determine the irritant potential of topical acne formulations on intact healthy skin on the back following repeated application during a 21-day treatment period

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2013

At a glance

  • Drugs Benzoyl peroxide/clindamycin (Primary) ; Adapalene; Petrolatum; Sodium lauril-sulfate; Tretinoin
  • Indications Acne vulgaris
  • Focus Adverse reactions
  • Sponsors Dow Pharmaceutical Sciences
  • Most Recent Events

    • 05 Jun 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top